Tocilizumab for Severe COVID-19 Infection and Multisystem Inflammatory Syndrome in Adults and Children

Tocilizumab for Severe COVID-19 Infection and Multisystem Inflammatory Syndrome in Adults and Children

Coronavirus disease 2019 (COVID-19) rapidly emerged as a global pandemic, placing imminent stress and burden on healthcare resources and workers worldwide. Many patients who present with a severe COVID-19 infection are at high risk of developing severe acute respiratory distress syndrome (ARDS), lea...

Full description

Bibliographic Details
Main Authors: Amber N. Edinoff, Edward Sanders Alpaugh, Olivia Newgaard, Irza Wajid, Rachel J. Klapper, Elyse M. Cornett, Adam M. Kaye, Praneet Iyer, Alan D. Kaye
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Life
Subjects:
tocilizumab
COVID-19
acute respiratory distress syndrome
IL-6
Online Access:https://www.mdpi.com/2075-1729/13/4/889

Internet

https://www.mdpi.com/2075-1729/13/4/889

Similar Items